{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:28:24Z","timestamp":1784302104550,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFC2305201"],"award-info":[{"award-number":["2022YFC2305201"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12763-3","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:33:30Z","timestamp":1773848010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of a HIV-1 drug resistance genotyping method based on high-throughput sequencing (HTS)"],"prefix":"10.1186","volume":"26","author":[{"given":"Jialu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wansi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2230-3718","authenticated-orcid":false,"given":"Yicong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3067-0908","authenticated-orcid":false,"given":"Hui","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3880-4744","authenticated-orcid":false,"given":"Lingjie","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"12763_CR1","volume-title":"The urgency of now: AIDS at a crossroads","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","year":"2024","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). The urgency of now: AIDS at a crossroads. Geneva: UNAIDS; 2024."},{"issue":"25","key":"12763_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.46234\/ccdcw2022.116","volume":"4","author":"M Li","year":"2022","unstructured":"Li M, Song C, Dong A, et al. Impact of HIV pretreatment drug resistance on virological failure after one-year antiretroviral therapy\u2014China, 2018\u20132019. China CDC Wkly. 2022;4(25):535\u201340. https:\/\/doi.org\/10.46234\/ccdcw2022.116.","journal-title":"China CDC Wkly"},{"issue":"10","key":"12763_CR3","doi-asserted-by":"publisher","first-page":"e0001948","DOI":"10.1371\/journal.pgph.0001948","volume":"3","author":"N Parkin","year":"2023","unstructured":"Parkin N, Harrigan PR, Inzaule S, Bertagnolio S. Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries. PLOS Glob Public Health. 2023;3(10):e0001948. https:\/\/doi.org\/10.1371\/journal.pgph.0001948.","journal-title":"PLOS Glob Public Health"},{"issue":"3","key":"12763_CR4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/jac\/dkac430","volume":"78","author":"S Balakrishna","year":"2023","unstructured":"Balakrishna S, Loosli T, Zaheri M, et al. Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1. J Antimicrob Chemother. 2023;78(3):656\u201364. https:\/\/doi.org\/10.1093\/jac\/dkac430.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"12763_CR5","doi-asserted-by":"publisher","first-page":"e00382","DOI":"10.1128\/JCM.00382-20","volume":"58","author":"D Bonsall","year":"2020","unstructured":"Bonsall D, Golubchik T, de Cesare M, et al. A comprehensive genomics solution for HIV surveillance and clinical monitoring in low-income settings. J Clin Microbiol. 2020;58(10):e00382\u201320. https:\/\/doi.org\/10.1128\/JCM.00382-20.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"12763_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/COH.0000000000000737","volume":"17","author":"KJ Metzner","year":"2022","unstructured":"Metzner KJ. Technologies for HIV-1 drug resistance testing: inventory and needs. Curr Opin HIV AIDS. 2022;17(4):222\u20138. https:\/\/doi.org\/10.1097\/COH.0000000000000737.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"12763_CR7","doi-asserted-by":"publisher","first-page":"8185","DOI":"10.1038\/s41598-020-65085-y","volume":"10","author":"G Sidhu","year":"2020","unstructured":"Sidhu G, Schuster L, Liu L, et al. A single variant sequencing method for sensitive and quantitative detection of HIV-1 minority variants. Sci Rep. 2020;10(1):8185. https:\/\/doi.org\/10.1038\/s41598-020-65085-y.","journal-title":"Sci Rep"},{"key":"12763_CR8","doi-asserted-by":"publisher","unstructured":"Hao J, Liu X, Wang D, et al. Transmitted human immunodeficiency virus type 1 (HIV-1) drug resistance among newly diagnosed individuals in 31 provincial-level administrative divisions in China in 2023: a cross-sectional survey. Clin Infect Dis. 2025;ciaf159. https:\/\/doi.org\/10.1093\/cid\/ciaf159.","DOI":"10.1093\/cid\/ciaf159"},{"key":"12763_CR9","doi-asserted-by":"publisher","first-page":"e50894","DOI":"10.2196\/50894","volume":"9","author":"H Chen","year":"2023","unstructured":"Chen H, Hao J, Hu J, et al. Pretreatment HIV drug resistance and the molecular transmission network among HIV-positive individuals in China in 2022: multicenter observational study. JMIR Public Health Surveill. 2023;9:e50894. https:\/\/doi.org\/10.2196\/50894.","journal-title":"JMIR Public Health Surveill"},{"key":"12763_CR10","doi-asserted-by":"publisher","unstructured":"Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM [Internet]. arXiv [Preprint]. 2013 [cited 2025 Jul 31]. Available from: https:\/\/doi.org\/10.48550\/arXiv.1303.3997.","DOI":"10.48550\/arXiv.1303.3997"},{"issue":"5","key":"12763_CR11","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","volume":"37","author":"BQ Minh","year":"2020","unstructured":"Minh BQ, Schmidt HA, Chernomor O, et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol. 2020;37(5):1530\u20134. https:\/\/doi.org\/10.1093\/molbev\/msaa015.","journal-title":"Mol Biol Evol"},{"key":"12763_CR12","volume-title":"WHO HIVResNet HIV drug resistance: laboratory operational framework. Annex 3. Recommended methods for validating an in-house genotyping assay for surveillance of HIV drug resistance","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. WHO HIVResNet HIV drug resistance: laboratory operational framework. Annex 3. Recommended methods for validating an in-house genotyping assay for surveillance of HIV drug resistance. Geneva: World Health Organization; 2020."},{"issue":"2","key":"12763_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1128\/JCM.02347-12","volume":"51","author":"S Inzaule","year":"2013","unstructured":"Inzaule S, Yang C, Kasembeli A, et al. Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country. J Clin Microbiol. 2013;51(2):529\u201339. https:\/\/doi.org\/10.1128\/JCM.02347-12.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"12763_CR14","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.3390\/v14102208","volume":"14","author":"CHY Teo","year":"2022","unstructured":"Teo CHY, Norhisham NHB, Lee OF, et al. Towards next-generation sequencing for HIV-1 drug resistance testing in a clinical setting. Viruses. 2022;14(10):2208. https:\/\/doi.org\/10.3390\/v14102208.","journal-title":"Viruses"},{"issue":"9","key":"12763_CR15","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/QAD.0000000000000267","volume":"28","author":"S Mohamed","year":"2014","unstructured":"Mohamed S, Penaranda G, Gonzalez D, et al. Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure. AIDS. 2014;28(9):1315\u201324. https:\/\/doi.org\/10.1097\/QAD.0000000000000267.","journal-title":"AIDS"},{"issue":"5","key":"12763_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/hiv.13038","volume":"22","author":"JD Baxter","year":"2021","unstructured":"Baxter JD, Dunn D, Tostevin A, et al. Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the strategic timing of antiretroviral treatment (START) study. HIV Med. 2021;22(5):360\u201371. https:\/\/doi.org\/10.1111\/hiv.13038.","journal-title":"HIV Med"},{"issue":"12","key":"12763_CR17","doi-asserted-by":"publisher","first-page":"e33180","DOI":"10.1016\/j.heliyon.2024.e33180","volume":"10","author":"P Appiah","year":"2024","unstructured":"Appiah P, Gbassana G, Adusei-Poku M, et al. Genetic landscape for majority and minority HIV-1 drug resistance mutations in antiretroviral therapy na\u00efve patients in Accra, Ghana. Heliyon. 2024;10(12):e33180. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33180.","journal-title":"Heliyon"},{"issue":"2","key":"12763_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/v16020239","volume":"16","author":"F Ouyang","year":"2024","unstructured":"Ouyang F, Yuan D, Zhai W, et al. HIV-1 drug resistance detected by next-generation sequencing among ART-na\u00efve individuals: a systematic review and meta-analysis. Viruses. 2024;16(2):239. https:\/\/doi.org\/10.3390\/v16020239.","journal-title":"Viruses"},{"issue":"3","key":"12763_CR19","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1093\/jac\/dku426","volume":"70","author":"A Cozzi-Lepri","year":"2015","unstructured":"Cozzi-Lepri A, Noguera-Julian M, Di Giallonardo F, et al. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing. J Antimicrob Chemother. 2015;70(3):930\u201340. https:\/\/doi.org\/10.1093\/jac\/dku426.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"12763_CR20","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/cid\/ciu287","volume":"59","author":"C Pou","year":"2014","unstructured":"Pou C, Noguera-Julian M, P\u00e9rez-\u00c1lvarez S, et al. Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing. Clin Infect Dis. 2014;59(4):578\u201388. https:\/\/doi.org\/10.1093\/cid\/ciu287.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"12763_CR21","first-page":"457","volume":"33","author":"AM Wensing","year":"2025","unstructured":"Wensing AM, Calvez V, Ceccherini-Silberstein F, et al. 2025 update of the drug resistance mutations in HIV-1. Top Antivir Med. 2025;33(2):457\u201373.","journal-title":"Top Antivir Med"},{"issue":"12","key":"12763_CR22","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.3390\/v16121888","volume":"16","author":"H Byun","year":"2024","unstructured":"Byun H, Papathanasopoulos MA, Steegen K, et al. Thymidine analogue mutations with M184V significantly decrease phenotypic susceptibility of HIV-1 subtype C reverse transcriptase to Islatravir. Viruses. 2024;16(12):1888. https:\/\/doi.org\/10.3390\/v16121888.","journal-title":"Viruses"},{"issue":"7","key":"12763_CR23","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3390\/v12070694","volume":"12","author":"NT Parkin","year":"2020","unstructured":"Parkin NT, Avila-Rios S, Bibby DF, et al. Multi-Laboratory comparison of Next-Generation to Sanger-Based sequencing for HIV-1 drug resistance genotyping. Viruses. 2020;12(7):694. https:\/\/doi.org\/10.3390\/v12070694.","journal-title":"Viruses"},{"issue":"4","key":"12763_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nmeth.1584","volume":"8","author":"T Kivioja","year":"2011","unstructured":"Kivioja T, V\u00e4h\u00e4rautio A, Karlsson K, et al. Counting absolute numbers of molecules using unique molecular identifiers. Nat Methods. 2011;8(4):287\u20139. https:\/\/doi.org\/10.1038\/nmeth.1584.","journal-title":"Nat Methods"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12763-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12763-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12763-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T03:16:48Z","timestamp":1777259808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12763-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12763"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12763-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"9 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants prior to enrollment in the study. The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Ethics Committee of NCAIDS Ethics Committee, China CDC (approval no. X140617334).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"838"}}